Asia-Pacific - Australia - Australia, New Zealand - Austria - Austria, Germany, Switzerland - Baltic countries - Bangladesh - Belgium - Brazil - Bulgaria - Canada - Canada, United States - China - Denmark - Europe - France - Germany - High-income countries - Ibero-America - India - International - Iran - Ireland - Italy - Japan - Latin America - Malta - Mexico - Middle East - Middle East, North Africa - Netherlands, Sweden - New Zealand - Norway - Republic of Korea - Saudi Arabia - Singapore - Spain - Spain, United Kingdom - Sweden - Switzerland - Taiwan - Thailand - Türkiye - United Kingdom - United States - {Related topics}

Asia-Pacific

• Journal of the Formosan Medical Association
  • Asia-pacific consensus on osteoporotic fracture prevention in postmenopausal women with low bone mass or osteoporosis but no fragility fractures [2023]

Australia

• Archives of Osteoporosis
  • Osteoporosis management in Australian aged care facilities: a mixed method study [2024]

• Australasian Journal on Ageing
  • Vitamin D, bones and muscle: myth versus reality [2017]

• Australian Family Physician
  • Medication selection and patient compliance in the clinical management of osteoporosis [2016]

• Australian Journal of General Practice
  • Menopause and osteoporosis: Non-pharmacological and pharmacological management [2026]

• Australian Prescriber
  • Treating osteoporosis: risks and management [2022]
  • Treating osteoporosis [2016]

• BMC Family Practice
  • Osteoporosis management in Australian general practice: an analysis of current osteoporosis treatment patterns and gaps in practice [2020]

• BMC Research Notes
  • Knowledge change regarding osteoporosis prevention: translating recommended guidelines into user-friendly messages within a community forum [2015]

• Cost Effectiveness and Resource Allocation
  • What are we paying for? A cost-effectiveness analysis of patented denosumab and generic alendronate for postmenopausal osteoporotic women in Australia [2016]

• Healthy Bones Australia
  • Exercise Prescription to Support the Management of Osteoporosis for Physiotherapists and Exercise Physiologists [2024]
  • Statement on Calcium and Vitamin D for Bone Health in Australian Adult Populations [2021]

• Internal Medicine
  • First-line treatment of osteoporosis with osteoanabolic therapy: a new opportunity [2025]

• Royal Australian College of General Practitioners
  • Recombinant human parathyroid hormone
  • Pharmacologic approaches to prevention and treatment
  • Menopausal Hormonal Therapy
  • Calcium, protein and Vitamin D
  • Bisphosphonates

Australia, New Zealand

• Australasian Menopause Society
  • Osteoporosis
  • Calcium Supplements

• Medical Journal of Australia
  • Calcium and bone health: position statement for the Australian and New Zealand Bone and Mineral Society, Osteoporosis Australia and the Endocrine Society of Australia [2009]

Austria

• Archives of Osteoporosis
  • Osteoporosis treatment in Austria-assessment of FRAX-based intervention thresholds for high and very high fracture risk [2022]

Austria, Germany, Switzerland

• BMC Endocrine Disorders
  • Exercise for fracture prevention - evidence and consensus-based practice guideline of the osteology umbrella association (DVO) [2026]

• Osteoporosis International
  • Exercise training and bone mineral density in postmenopausal women: an updated systematic review and meta-analysis of intervention studies with emphasis on potential moderators [2023]

Baltic countries

• Medicina
  • Use of drugs against osteoporosis in the Baltic countries during 2010–2014 [2016]

Bangladesh

• Asia Pacific Journal of Clinical Nutrition
  • Vitamin D deficiency in Bangladesh: A review of prevalence, causes and recommendations for mitigation [2022]

Belgium

• Belgian Bone Club
  • When and How to Evaluate Vitamin D Status? A Viewpoint from the Belgian Bone Club [2024]
  • Effects of Dairy Products Consumption on Health: Benefits and Beliefs—A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases [2015]
  • Extraskeletal benefits and risks of calcium, Vitamin D and anti-osteoporosis medications [2012]
  • Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club [2011]
  • Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club [2010]
  • Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club [2009]

• Osteoporosis International
  • Cost-effectiveness of romosozumab for the treatment of postmenopausal women with osteoporosis at high risk of fracture in Belgium [2024]

Brazil

• Archives of Endocrinology and Metabolism
  • Definition and management of very high fracture risk in women with postmenopausal osteoporosis: a position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Association of Bone Assessment and Metabolism (ABRASSO) [2022]

Bulgaria

• Rheumatology and Therapy
  • Clinical Management of Women with Newly Diagnosed Osteoporosis: Data from Everyday Practice in Bulgaria [2021]

Canada

• Alberta Health Services
  • Nutrition Guideline - Calcium and Vitamin D for Prevention and Treatment of Osteoporosis

• Archives of Osteoporosis
  • Cost-effectiveness of romosozumab for the treatment of postmenopausal women at very high risk of fracture in Canada [2022]

• BCGuidelines
  • Vitamin D Testing

• BMC Geriatrics
  • Strategies to overcome barriers to implementing osteoporosis and fracture prevention guidelines in long-term care: a qualitative analysis of action plans suggested by front line staff in Ontario, Canada [2015]

• Canada's Drug Agency
  • Vitamin D Supplementation for the Prevention of Falls and Fractures in Residents of Long-Term Care Facilities: A 2021 Update [2021]
  • Duration of Bisphosphonate Treatment for Patients with Osteoporosis: A Review of Clinical Effectiveness and Guidelines [2019]
  • Vitamin D Testing in the General Population: A Review of the Clinical and Cost-Effectiveness and Guidelines [2015]
  • Denosumab, Raloxifene, and Zoledronic Acid for the Treatment of Postmenopausal Osteoporosis: Clinical Effectiveness and Harms [2013]

• Canadian Academy of Sport and Exercise Medicine
  • Canadian Academy of Sport and Exercise Medicine Position Statement: Osteoporosis and Exercise [2013]

• Canadian Family Physician
  • Vitamin D and fracture prevention [2025]
  • Reduce unnecessary routine vitamin D testing [2023]
  • Bisphosphonates: forever or 5 years and stop? [2015]
  • Bisphosphonates for treatment of osteoporosis. Expected benefits, potential harms, and drug holidays [2014]

• Journal of Osteoporosis
  • Characterizing the Assessment and Management of Vitamin D Levels in Patients with Osteoporosis in Clinical Practice: A Chart Review Initiative [2015]

• MDM Policy & Practice
  • Cost-Effectiveness of Pharmacological Treatments for Osteoporosis Consistent with the Revised Economic Evaluation Guidelines for Canada [2019]

• Osteoporosis Canada
  • Recommendations for preventing fracture in long-term care [2015]
  • Parathyroid hormone for the treatment of osteoporosis: a systematic review [2006]
  • Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis [2006]
  • Vitamin D
  • Calcium
  • Bisphosphonates

Canada, United States

• Osteoporosis International
  • Fracture definitions in observational osteoporosis drug effects studies that leverage healthcare administrative (claims) data: a scoping review [2022]

China

• Bioengineered
  • Chinese patent medicine for osteoporosis: a systematic review and meta-analysis [2022]

• Clinical Interventions in Aging
  • Management of osteoporosis with calcitriol in elderly Chinese patients: a systematic review [2014]

• Drug Design, Development and Therapy
  • A Health Technology Assessment Based on Chinese Guideline: Active Vitamin D and Its Analogs in the Treatment of Osteoporosis [2024]

• Frontiers in Endocrinology
  • Expert consensus on the bone repair strategy for osteoporotic fractures in China [2022]

• Frontiers in Public Health
  • Cost-effectiveness analysis of Chinese patent medicines for the treatment of postmenopausal osteoporosis in China [2025]
  • Cost-Effectiveness of Sequential Teriparatide/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China [2022]

• Nutrients
  • Associations of Serum Homocysteine with Bone Mineral Density and Osteoporosis Incidence in Chinese Middle-Aged and Older Adults: A Retrospective Cohort Study [2025]

• Osteoporosis International
  • Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China: a cost-effectiveness analysis based on real-world data [2020]

• PeerJ
  • A retrospective analysis of anti-osteoporosis medication trends among patients under 50 years old in nine major regions of China from 2016 to 2019 [2025]

Denmark

• International Journal of Circumpolar Health
  • The prevalence of patients treated for osteoporosis in Greenland is low compared to Denmark [2022]

• Journal of Bone and Mineral Research
  • Life Expectancy in Patients Treated for Osteoporosis: Observational Cohort Study Using National Danish Prescription Data [2015]

• Journal of Clinical Endocrinology & Metabolism
  • Bisphosphonate Use and Risk of Atypical Femoral Fractures: A Danish Case-Cohort Study With Blinded Radiographic Review [2024]

Europe

• Archives of Osteoporosis
  • Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium [2017]

• Calcified Tissue International
  • Effects of Teriparatide in Patients with Osteoporosis in Clinical Practice: 42-Month Results During and After Discontinuation of Treatment from the European Extended Forsteo® Observational Study (ExFOS) [2018]

• European Alliance of Associations for Rheumatology
  • EULAR/EFORT recommendations for management of patients older than 50 years with a fragility fracture and prevention of subsequent fractures [2017]

• European Calcified Tissue Society
  • Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society [2020]
  • Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS [2020]

• European Menopause and Andropause Society
  • EMAS position statement: Vitamin D and menopausal health [2023]
  • Calcium in the prevention of postmenopausal osteoporosis: EMAS clinical guide [2018]
  • Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement [2017]
  • EMAS position statement: The management of postmenopausal women with vertebral osteoporotic fracture [2014]

• European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
  • Treatment of Osteoporosis and Osteoarthritis in the Oldest Old [2025]
  • Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group [2022]
  • Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis? [2020]
  • Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review [2020]
  • Cutaneous Side Effects of Antiosteoporosis Treatments [2011]
  • Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report [2010]

• European Union Geriatric Medicine Society
  • A Comprehensive Fracture Prevention Strategy in Older Adults: The European Union Geriatric Medicine Society (EUGMS) Statement [2016]

• Osteoporosis International
  • The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study [2021]
  • Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study [2015]

France

• International Journal of Environmental Research and Public Health
  • Bisphosphonate Use and Hospitalization for Hip Fractures in Women: An Observational Population-Based Study in France [2021]

• Joint Bone Spine
  • Daily or intermittent vitamin D supplementation in patients with or at risk of osteoporosis: Position statement from the GRIO [2025]

• Osteoporosis International
  • Public health impact and economic evaluation of vitamin D-fortified dairy products for fracture prevention in France [2017]

• PLoS ONE
  • Low Osteoporosis Treatment Initiation Rate in Women after Distal Forearm or Proximal Humerus Fracture: A Healthcare Database Nested Cohort Study [2015]

• Scientific Reports
  • Adherence with brand versus generic bisphosphonates among osteoporosis patients: a new-user cohort study in the French National Healthcare Insurance database [2020]

Germany

• Geburtshilfe und Frauenheilkunde
  • Bone-Targeted Therapy [2015]

• Injury
  • Association of orthogeriatric co-management with prescription frequencies of anti-osteoporotic drugs in patients with fragility fractures: An observational study with health insurance data [2024]

• Institute for Quality and Efficiency in Health Care
  • Bisphosphonates, teriparatide and deno-sumab for the treatment of postmenopausal osteoporosis [2023]

High-income countries

• American Journal of Medicine
  • Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study [2015]

• BMJ Open
  • Acceptability of bisphosphonates among patients, clinicians and managers: a systematic review and framework synthesis [2020]

• Cochrane Database of Systematic Reviews
  • Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women [2024]

Ibero-America

• Archives of Osteoporosis
  • Recommendations for the prevention of fragility fractures: a consensus from international experts and Ibero-American scientific societies [2025]

India

• Frontiers in Endocrinology
  • Modern India and the Tale of Twin Nutrient Deficiency–Calcium and Vitamin D–Nutrition Trend Data 50 Years-Retrospect, Introspect, and Prospect [2019]

• Nutrients
  • Vitamin D Deficiency in India: Prevalence, Causalities and Interventions [2014]

International

• Age and Ageing
  • Initiation of anti-osteoporosis medication following hip fracture in older adults: a systematic review and thematic synthesis of qualitative studies from patient and healthcare professional perspectives [2025]

• Annals of Joint
  • Expert consensus on vitamin D in osteoporosis [2025]

• Archives of Osteoporosis
  • Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials [2024]

• Archives of Public Health
  • A systematic review of evidence-based clinical guidelines for vitamin D screening and supplementation over the last decade [2025]

• BMJ
  • Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis [2026]
  • Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials [2023]

• BMJ Open
  • Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review [2019]

• Bone Reports
  • The efficacy of teriparatide on lumbar spine bone mineral density, vertebral fracture incidence and pain in post-menopausal osteoporotic patients: A systematic review and meta-analysis [2020]

• Cochrane Database of Systematic Reviews
  • Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women [2025]
  • Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women [2022]

• Current Osteoporosis Reports
  • Calcium Supplementation- Efficacy and Safety [2025]
  • Nutrition and Osteoporosis Prevention [2024]

• Drug Design, Development and Therapy
  • Effectiveness of Sequential Treatment with Zoledronic Acid Following Discontinuation of Denosumab in Osteoporosis: A Narrative Review [2025]

• Drugs & Aging
  • Treatment Considerations for Severe Osteoporosis in Older Adults [2025]

• Endocrine Practice
  • Antiresorptive Therapy to Reduce Fracture Risk and Effects on Dental Implant Outcomes in Patients With Osteoporosis: A Systematic Review and Osteonecrosis of the Jaw Taskforce Consensus Statement [2025]

• Endocrine Reviews
  • Management of postmenopausal osteoporosis [2026]
  • Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows [2024]

• European Journal of Endocrinology
  • Extensive expertise in endocrinology: advances in the management of glucocorticoid-induced osteoporosis [2023]
  • ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of calcium metabolic disorders and osteoporosis [2020]

• European Journal of Physical and Rehabilitation Medicine
  • Osteoporosis guidelines from a rehabilitation perspective: systematic analysis and quality appraisal using AGREE II [2021]

• European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
  • Recommendations for the optimal use of bone forming agents in osteoporosis [2024]
  • Novel formulations of oral bisphosphonates in the treatment of osteoporosis [2022]
  • Management of patients at very high risk of osteoporotic fractures through sequential treatments [2022]
  • Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs [2020]
  • Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF) [2019]
  • The role of calcium supplementation in healthy musculoskeletal ageing: An Experts consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF) [2017]

• Expert Opinion on Biological Therapy
  • Biosimilars in osteoporosis treatment: focus on denosumab [2025]

• Expert Review of Pharmacoeconomics & Outcomes Research
  • The economic benefits of fracture prevention [2025]

• Frontiers in Endocrinology
  • Efficacy and safety of abaloparatide, denosumab, teriparatide, oral bisphosphonates, and intravenous bisphosphonates in the treatment of postmenopausal osteoporosis: a systematic review and Bayesian network meta-analysis [2026]
  • Assessment of the efficacy and safety of anti-sclerostin antibody therapy for osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials [2026]
  • The effect of non-pharmacological interventions on bone health among patients with low bone mass: a systematic review and meta-analysis [2025]
  • Effects of exercise on bone metabolism in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials [2025]
  • The Effect of Bisphosphonates on Fracture Healing Time and Changes in Bone Mass Density: A Meta-Analysis [2021]

• Frontiers in Reproductive Health
  • Impact of menopause hormone therapy, exercise, and their combination on bone mineral density and mental wellbeing in menopausal women: a scoping review [2025]

• Heliyon
  • Efficacy and safety of zoledronic acid in the treatment of osteoporosis: A meta-analysis of randomized controlled trials [2024]

• Integrative Medicine Research
  • What traditional, complementary, and integrative medicine recommendations exist across osteoporosis clinical practice guidelines? A systematic review and quality assessment [2022]

• International Journal of Behavioral Nutrition and Physical Activity
  • Evidence on physical activity and osteoporosis prevention for people aged 65+ years: a systematic review to inform the WHO guidelines on physical activity and sedentary behaviour [2020]

• International Journal of Environmental Research and Public Health
  • Effects of Multicomponent Exercise Training on the Health of Older Women with Osteoporosis: A Systematic Review and Meta-Analysis [2022]

• International Journal of Rheumatic Diseases
  • Romosozumab Versus Teriparatide for the Treatment of Postmenopausal Osteoporosis: An Overview of Systematic Reviews With Direct and Indirect Meta-Analyses [2026]

• International Osteoporosis Foundation
  • Impact of osteoporosis and osteoporosis medications on fracture healing: a narrative review [2024]
  • The global approach to rehabilitation following an osteoporotic fragility fracture: A review of the rehabilitation working group of the International Osteoporosis Foundation (IOF) committee of scientific advisors [2022]
  • How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey [2021]
  • International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates [2017]
  • Global dietary calcium intake among adults: a systematic review [2017]
  • Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle [2013]
  • Vitamin D
  • Treatment
  • Prevention
  • Nutrition and lifestyle
  • MHT & SERM
  • Calcium
  • Bisphosphonates

• Journal of Advanced Research
  • A comprehensive review and advanced biomolecule-based therapies for osteoporosis [2025]

• Journal of Clinical Endocrinology & Metabolism
  • Health and adverse events associated with extended oral bisphosphonates among postmenopausal women: a systematic review [2026]

• Journal of Education and Health Promotion
  • Prevention of osteoporosis in menopausal women: A systematic review of nonpharmacological clinical trials [2022]

• Journal of Frailty & Aging
  • Osteoporosis in Frail Older Adults: Recommendations for Research from the ICFSR Task Force 2020 [2021]

• Journal of Orthopaedic Surgery and Research
  • Optimal resistance training parameters for improving bone mineral density in postmenopausal women: a systematic review and meta-analysis [2025]

• Lancet Healthy Longevity
  • The effects of anti-osteoporotic medication on fracture healing and outcomes: a systematic review and meta-analysis [2026]

• Medicine
  • Efficacy and safety of denosumab compared with conventional medications in the treatment of osteoporosis: A meta-analysis with trial sequential analysis [2026]
  • Quality assessment of traditional and conventional medicine clinical practice guidelines for osteoporosis [2021]

• Nature Reviews Rheumatology
  • WHO benchmarks for equitable hip-fracture care and osteoporosis treatment in older people [2026]

• Nutrients
  • Daily Calcium and Vitamin D Supplementation as a Foundational Pillar in Osteoporosis Management: A Narrative Review [2026]
  • Rethinking Vitamin D Deficiency: Controversies and Practical Guidance for Clinical Management [2025]
  • Effects of Combined Exercise and Calcium/Vitamin D Supplementation on Bone Mineral Density in Postmenopausal Women: A Systematic Review and Meta-Analysis [2025]
  • Determinants and Effects of Vitamin D Supplementation in Postmenopausal Women: A Systematic Review [2023]
  • Assessment of the Methods Used to Develop Vitamin D and Calcium Recommendations—A Systematic Review of Bone Health Guidelines [2021]

• Osteoporosis and Sarcopenia
  • Nonpharmacological interventions for osteoporosis treatment: Systematic review of clinical practice guidelines [2019]

• Osteoporosis International
  • PTH1 receptor agonists for fracture risk: a systematic review and network meta-analysis [2025]
  • Pharmacist interventions in osteoporosis management: a systematic review [2023]
  • Post-fracture care programs for prevention of subsequent fragility fractures: a literature assessment of current trends [2022]
  • Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures [2019]
  • Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures [2017]
  • Assessment of health claims in the field of bone: a view of the Group for the Respect of Ethics and Excellence in Science (GREES) [2012]

• Patient
  • Stated Preferences of At-Risk Populations for the Treatment of Osteoporosis: A Systematic Review [2024]

• PeerJ
  • Effects of exercise interventions on health-related quality of life in older adults with osteoporosis: a systematic review and meta-analysis [2026]
  • Effects of dietary supplements on bone turnover markers in women after menopause: a network meta-analysis [2025]

• PharmacoEconomics
  • An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis [2021]

• PM&R
  • Effects of exercise on bone density and physical performance in postmenopausal women: A systematic review and meta-analysis [2024]

• Public Health Nutrition
  • 25-Hydroxyvitamin D assay standardisation and vitamin D guidelines paralysis [2020]

• Sao Paulo Medical Journal
  • Intravenous zoledronate for postmenopausal women with osteopenia and osteoporosis: a systematic review and metanalysis [2023]

• Science Progress
  • Does alendronate enhance survival rates in osteoporosis patients? A meta-analysis of randomized controlled trials [2025]

• Scientific Reports
  • Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis [2020]

• Therapeutic Advances in Musculoskeletal Disease
  • Update on the safety and efficacy of teriparatide in the treatment of osteoporosis [2019]

• Women's Health
  • Estrogen hormone therapy and postmenopausal osteoporosis: does it really take two to tango? [2023]

• World Federation of Neurosurgical Societies
  • Vertebral augmentation in osteoporotic spine fractures: WFNS Spine Committee recommendations [2022]
  • Decompression and fusion surgery for osteoporotic vertebral fractures: WFNS spine committee recommendations [2022]

Iran

• Iranian Journal of Pharmaceutical Research
  • Teriparatide in the Treatment of Severe Postmenopausal Osteoporosis: A Cost-Utility Analysis [2019]

• Medical Journal of the Islamic Republic of Iran
  • Cost-effectiveness of teriparatide compared with alendronate and risedronate for the treatment of postmenopausal osteoporosis patients in Iran [2017]

Ireland

• Age and Ageing
  • Factors associated with initiation of bone-health medication among older adults in primary care in Ireland [2021]

• Archives of Osteoporosis
  • Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland [2021]

• British Journal of Clinical Pharmacology
  • Utilization and expenditure on medicines for the management of osteoporosis in Ireland: A repeated cross-sectional study [2025]

• Irish Nutrition and Dietetic Institute
  • Osteoporosis: A Nutrition Fact Sheet for Health Professionals

Italy

• Archives of Osteoporosis
  • The essential role of combined calcium and vitamin D supplementation in the osteoporosis scenario in italy: Expert opinion paper [2024]

• Journal of Orthopaedics and Traumatology
  • Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology [2017]

• Nutrients
  • Definition, Assessment, and Management of Vitamin D Inadequacy: Suggestions, Recommendations, and Warnings from the Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS) [2022]
  • Italian Association of Clinical Endocrinologists (AME) and Italian Chapter of the American Association of Clinical Endocrinologists (AACE) Position Statement: Clinical Management of Vitamin D Deficiency in Adults [2018]

• Reumatismo
  • Expert opinion on the management of patients with osteoporosis with anabolic drugs in Italy [2024]

Japan

• Archives of Osteoporosis
  • Trends in the prevalence of hypovitaminosis D over a 10-year period in Japan: the research on osteoarthritis/osteoporosis against disability study 2005-2015 [2025]
  • Japanese 2011 guidelines for prevention and treatment of osteoporosis - executive summary [2012]

• Bone
  • Trends in anti-osteoporosis pharmacotherapy and pharmacological initiation for secondary fracture prevention in Japan, 2017-2023 [2026]

• Clinical Interventions in Aging
  • Safety and effectiveness of daily teriparatide in a prospective observational study in patients with osteoporosis at high risk of fracture in Japan: final report [2016]
  • Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia) [2014]

• Endocrine Journal
  • Assessment criteria for vitamin D deficiency/insufficiency in Japan — proposal by an expert panel supported by Research Program of Intractable Diseases, Ministry of Health, Labour and Welfare, Japan [2016]

• Journal of Epidemiology
  • Effect of Distributing an Evidence-Based Guideline for Prevention of Osteoporosis on Health Education Programs in Municipal Health Centers: A Randomized Controlled Trial [2012]

• Journal of Orthopaedic Science
  • Current status of patients with hip fracture in Japan: A nationwide survey [2026]

• Osteoporosis and Sarcopenia
  • Safety and efficacy in actual clinical practice of once-weekly subcutaneous teriparatide for osteoporosis patients with a high fracture risk [2019]

• Scientific Reports
  • Prescription of vitamin D was associated with a lower incidence of hip fractures [2023]

Latin America

• Archives of Osteoporosis
  • Clinical Practice Guidelines of the Latin American Federation of Endocrinology for the use of vitamin D in the maintenance of bone health: recommendations for the Latin American context [2024]

Malta

• Surgery Journal
  • Hip Fractures in Malta: Are we Missing an Opportunity? [2021]

Mexico

• PLoS ONE
  • Cost-effectiveness analysis of romosozumab for severe postmenopausal osteoporosis at very high risk of fracture in Mexico [2025]

Middle East

• Journal of International Medical Research
  • Middle East experience from the Asia And Latin America Fracture Observational Study (ALAFOS): Baseline characteristics of postmenopausal women with osteoporosis using teriparatide [2020]

Middle East, North Africa

• Bone Reports
  • Vitamin D in the Middle East and North Africa [2018]

Netherlands, Sweden

• Archives of Osteoporosis
  • Exploring methods for comparing the real-world effectiveness of treatments for osteoporosis: adjusted direct comparisons versus using patients as their own control [2017]

New Zealand

• Starship
  • Endocrinology - intravenous bisphosphonate therapy

Norway

• Osteoporosis International
  • Time-varying exposure to anti-osteoporosis drugs and risk of first-time hip fracture: a population wide study within the Norwegian Epidemiologic Osteoporosis Studies (NOREPOS) [2023]
  • Does treatment with bisphosphonates protect against fractures in real life? The HUNT study, Norway [2021]

Republic of Korea

• BMC Musculoskeletal Disorders
  • Association between osteoporosis under treatment and all-cause and specific-cause mortalities: a nationwide retrospective cohort study in South Korea [2025]
  • Association between the awareness of osteoporosis and the quality of care for bone health among Korean women with osteoporosis [2014]

• Clinics in Orthopedic Surgery
  • Effects of Osteoporosis Medication Use on Reprocedure Rates Following Vertebral Augmentation: A Nationwide Cohort Study [2025]

• Endocrinology and Metabolism
  • Comprehensive Evaluation of Treatment Patterns in Postmenopausal Patients with Osteoporosis without Fractures: Insights from Tertiary Care Institutions and Nationwide OMOP-CDM Data [2025]

• Journal of Bone Metabolism
  • Position Statement: Vitamin D Intake to Prevent Osteoporosis and Fracture in Adults [2022]
  • The Trend in the Sales of Menopausal Hormone and Other Osteoporosis Medications in South Korea from 2016 to 2019 [2021]
  • Position Statement: Exercise Guidelines to Increase Peak Bone Mass in Adolescents [2019]
  • Cost-effectiveness of Pharmaceutical Interventions to Prevent Osteoporotic Fractures in Postmenopausal Women with Osteopenia [2016]
  • Position Statement: Drug Holiday in Osteoporosis Treatment with Bisphosphonates in South Korea [2015]
  • Medication Related Osteonecrosis of the Jaw: 2015 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons [2015]
  • Calcium and Vitamin D Supplementations: 2015 Position Statement of the Korean Society for Bone and Mineral Research [2015]
  • National Healthcare Budget Impact Analysis of the Treatment for Osteoporosis and Fractures in Korea [2013]

• Journal of Korean Medical Science
  • Factors Associated With Compliance and Persistence With Pharmacotherapy in Patients With Osteoporosis: A Nationwide Cohort Study in Korea [2025]
  • Incidence and Risk of Venous Thromboembolism in Bisphosphonates and Selective Estrogen Receptor Modulators Treatment in Korea [2021]
  • Hip and Subtrochanteric or Femoral Shaft Fractures after Bisphosphonate Use in Korean Women, Using Korean National Sample Cohort [2020]

• Medicina
  • Five-Year Sales Trends of Osteoporosis Medications in Korea: A Market Analysis Based on IMS Health Sales Audit Data (2018-2023) [2025]

• Nutrients
  • Association of Dietary Total Antioxidant Capacity with Bone Mass and Osteoporosis Risk in Korean Women: Analysis of the Korea National Health and Nutrition Examination Survey 2008–2011 [2021]

• Osteoporosis and Sarcopenia
  • The secular trends in the use of medications for osteoporosis in South Korea using Intercontinental Medical Statistics Health Sales Audit 2006–2018 [2020]

• PLoS ONE
  • Comparison of the Prescribing Pattern of Bisphosphonate and Raloxifene in Korean Women with Osteoporosis: From a National Health Insurance Claims Database [2015]

• Yonsei Medical Journal
  • Association between Daily Sunlight Exposure and Fractures in Older Korean Adults with Osteoporosis: A Nationwide Population-Based Cross-Sectional Study [2021]

Saudi Arabia

• Archives of Osteoporosis
  • Vitamin D status correction in Saudi Arabia: an experts’ consensus under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (ESCEO) [2016]

Singapore

• Osteoporosis International
  • Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women [2021]

Spain

• ClinicoEconomics and Outcomes Research
  • Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain [2013]

• Drugs in R&D
  • Identifying and managing patients at high risk for fractures: conclusions from the second Spanish multidisciplinary forum-parathyroid hormone use in osteoporotic patients at high risk for fractures [2012]

• Medicina Clínica
  • PTH/PTHrP analogues as osteoanabolic treatment in patients with osteoporosis [2025]

• Nutrients
  • Cholecalciferol or Calcifediol in the Management of Vitamin D Deficiency [2020]

• Osteoporosis International
  • Contemporary pharmacological management of patients after hip fracture: a population-based cohort of over 120,000 patients in Spain [2025]

• PLoS ONE
  • Overuse and Underuse of Antiosteoporotic Treatments According to Highly Influential Osteoporosis Guidelines: A Population-Based Cross-Sectional Study in Spain [2015]

• Revista Clínica Española (English Edition)
  • Update of the SEIOMM clinical guideline of osteoporosis: abaloparatide [2025]

Spain, United Kingdom

• Clinical Epidemiology
  • Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on “real-world” data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database [2018]

Sweden

• Archives of Osteoporosis
  • Secondary fracture prevention with osteoporosis medication after a fragility fracture in Sweden remains low despite new guidelines [2023]

Switzerland

• Archives of Osteoporosis
  • The osteoporosis treatment gap in Switzerland between 1998 and 2018 [2023]

• Bone
  • Long-term impact of teriparatide on bone mineral density, trabecular bone score, and fracture risk relative to total hip T-score: A two-decade, registry-based cohort study [2025]

• Swiss Medical Weekly
  • 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO) [2020]

Taiwan

• Aging
  • The association between osteoporosis medications and lowered all-cause mortality after hip or vertebral fracture in older and oldest-old adults: a nationwide population-based study [2022]

• BMC Geriatrics
  • Adherence to anti-osteoporosis medication associated with lower mortality following hip fracture in older adults: a nationwide propensity score-matched cohort study [2019]

• Frontiers in Endocrinology
  • Denosumab treatment and infection risks in patients with osteoporosis: propensity score matching analysis of a national-wide population-based cohort study [2023]

• Journal of Bone and Mineral Research
  • The Impact of Various Anti-Osteoporosis Drugs on All-Cause Mortality After Hip Fractures: A Nationwide Population Study [2022]

• Journal of the Formosan Medical Association
  • Eleven years secular trend of the initiation of anti-osteoporosis medications and subsequent fractures in Taiwan: From 2008 to 2018 [2023]
  • Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update [2023]
  • The impact of bisphosphonates on mortality and cardiovascular risk among osteoporosis patients after cardiovascular disease [2021]

• Mayo Clinic Proceedings
  • Long Dosing Intervals of Parenteral Antiosteoporosis Medications and the Decrease in Societal Fracture Risk: An 11-Year Nationwide Population-Based Cohort Study [2025]

Thailand

• Injury
  • A multidisciplinary approach to post-operative fragility hip fracture care in Thailand - a narrative review [2023]

Türkiye

• Nutrients
  • Best Practice Recommendations for the Assessment, Prevention and Treatment of Vitamin D Deficiency in Türkiye: A 2026 Update in a Setting with Limited Mandatory Food Fortification [2026]

• Osteoporosis International
  • No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study [2021]

United Kingdom

• Age and Ageing
  • New national osteoporosis guidance-implications for geriatricians [2022]

• Archives of Osteoporosis
  • Current approaches to secondary prevention after hip fracture in England and Wales - an analysis of trends between 2016 and 2020 using the National Hip Fracture Database (NHFD) [2023]

• Bone
  • Trends in oral anti-osteoporosis drug prescription in the United Kingdom between 1990 and 2012: variation by age, sex, geographic location and ethnicity [2017]

• British Menopause Society
  • Prevention and treatment of osteoporosis in women [2023]

• Health Technology Assessment
  • Bisphosphonate alternative regimens for the prevention of osteoporotic fragility fractures: BLAST-OFF, a mixed-methods study [2024]
  • Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation [2020]
  • Exercise or manual physiotherapy compared with a single session of physiotherapy for osteoporotic vertebral fracture: three-arm PROVE RCT [2019]

• Journal of Orthopaedic Surgery and Research
  • Secondary prevention of osteoporosis in non-neck of femur fragility fractures: is it value for money? A retrospective, prospective and cross-sectional cohort study [2013]

• Medicines and Healthcare products Regulatory Agency
  • Bisphosphonates: use and safety

• National Institute for Health and Care Excellence
  • Abaloparatide for treating osteoporosis after menopause [2024]
  • Romosozumab for treating severe osteoporosis [2022]
  • COVID-19 rapid guideline: vitamin D [2022]
  • Bisphosphonates for treating osteoporosis [2019]
  • Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women [2018]
  • Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women [2018]
  • Vitamin D: supplement use in specific population groups [2017]
  • Denosumab for the prevention of osteoporotic fractures in postmenopausal women [2010]

• National Osteoporosis Guideline Group
  • The 2024 UK clinical guideline for the prevention and treatment of osteoporosis [2025]
  • Non-pharmacological management of osteoporosis [2024]
  • Clinical Guideline for the Prevention and Treatment of Osteoporosis [2024]
  • UK clinical guideline for the prevention and treatment of osteoporosis [2022]

• NHS England
  • Calcium and vitamin D (colecalciferol) preparations for adults at risk of osteoporosis [2023]

• Office for Health Improvement and Disparities
  • Musculoskeletal health: applying All Our Health
  • Falls and fractures: applying All Our Health

• Osteoporosis International
  • Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study [2017]
  • Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000–2010 [2015]

• Public Health England
  • Vitamin D supplementation during winter: PHE and NICE statement

• Royal Osteoporosis Society
  • Supporting patients to get the best from their osteoporosis treatment: a rapid realist review of what works, for whom, and in what circumstance [2022]
  • Strong, steady and straight: UK consensus statement on physical activity and exercise for osteoporosis [2022]
  • Vitamin D and Bone Health: A Practical Clinical Guideline [2020]
  • Effective secondary prevention of fragility fractures: Clinical standards for Fracture Liaison Services [2019]

United States

• Agency for Healthcare Research and Quality
  • Association Between Outcomes and Dental Services in People Receiving Treatments That Cause Medication-Related Osteonecrosis of the Jaw: A Rapid Response Review [2025]
  • Screening for Vitamin D Deficiency in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force [2021]
  • Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review [2019]
  • Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: An Evidence Review for the U.S. Preventive Services Task Force [2018]
  • Changes in Osteoporosis Medication Use and Expenditures among Women (Age >= 50), United States, 2000 to 2011 [2014]
  • Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis: Update of a 2007 Report [2012]

• American Academy of Pediatrics
  • Optimizing Bone Health in Children and Adolescents [2014]

• American College of Physicians
  • Update Alert: Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians [2024]
  • Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians (Version 1, Update Alert) [2024]
  • Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians [2023]
  • Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians [2023]
  • Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women [2017]

• American Journal of Medicine
  • Reconsidering the Benefits of Osteoporosis Treatment: The Case of Bisphosphonates [2024]

• American Physical Therapy Association
  • Physical Therapist Management of Patients With Suspected or Confirmed Osteoporosis: A Clinical Practice Guideline From the Academy of Geriatric Physical Therapy [2022]

• American Society for Bone and Mineral Research
  • Goal-directed osteoporosis treatment: ASBMR/BHOF task force position statement 2024 [2024]
  • Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition [2020]
  • Osteoporosis therapeutics: recent developments at ASBMR [2016]
  • Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research [2016]
  • Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research [2014]
  • Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention [2012]
  • Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research [2007]

• Annals of Pharmacotherapy
  • Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United States [2019]

• Archives of Osteoporosis
  • Shifting bisphosphonate prescribing patterns for fracture prevention: a 24-year national surveillance of men in the U.S. Veterans Health Administration [2026]
  • A comprehensive update on the cost-effectiveness of 10-year denosumab vs alendronate in postmenopausal women with osteoporosis in the United States [2025]

• Bone Health & Osteoporosis Foundation
  • The clinician's guide to prevention and treatment of osteoporosis [2022]
  • Animal versus plant protein and adult bone health: A systematic review and meta-analysis from the National Osteoporosis Foundation [2018]
  • Lack of Evidence Linking Calcium With or Without Vitamin D Supplementation to Cardiovascular Disease in Generally Healthy Adults: A Clinical Guideline From the National Osteoporosis Foundation and the American Society for Preventive Cardiology [2016]
  • Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation [2015]
  • Clinician’s Guide to Prevention and Treatment of Osteoporosis [2014]

• Cleveland Clinic Journal of Medicine
  • Teriparatide: Label changes and identifying patients for long-term use [2021]

• Cureus
  • Profile of Abaloparatide and Its Potential in the Treatment of Postmenopausal Osteoporosis [2017]

• Current Osteoporosis Reports
  • Parathyroid Hormone and Parathyroid Hormone-related Protein Analogs as Therapies for Osteoporosis [2013]

• Drug Discovery Today
  • Treating osteoporosis by targeting parathyroid hormone to bone [2014]

• Endocrine Connections
  • Vitamin D dose response is underestimated by Endocrine Society's Clinical Practice Guideline [2013]

• Endocrine Practice
  • Comparative Effectiveness of Abaloparatide and Teriparatide in Women 50 Years of Age and Older: Update of a Real-World Retrospective Analysis [2025]

• Endocrine Society
  • Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline [2024]
  • Vitamin D Insufficiency and Epistemic Humility: An Endocrine Society Guideline Communication [2024]
  • A Systematic Review Supporting the Endocrine Society Clinical Practice Guidelines on Vitamin D [2024]
  • Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update [2020]
  • Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline [2019]

• Endotext
  • Osteoporosis: Prevention and Treatment

• Foundation for the National Institutes of Health
  • The relationship between treatment-related changes in total hip BMD measured after 12, 18, and 24 mo and fracture risk reduction in osteoporosis clinical trials: the FNIH-ASBMR-SABRE project [2024]
  • Pre-treatment bone mineral density and the benefit of pharmacologic treatment on fracture risk and BMD change: analysis from the FNIH-ASBMR SABRE project [2024]
  • Influence of age on the efficacy of pharmacologic treatments on fracture risk reduction and increases in BMD: RCT results from the FNIH-ASBMR-SABRE project [2024]
  • Validation of the Surrogate Threshold Effect for Change in Bone Mineral Density as a Surrogate Endpoint for Fracture Outcomes: The FNIH-ASBMR SABRE Project [2023]

• Hand
  • Declining Trend in Anti-osteoporotic Treatment, Despite a Rise in DEXA Screening Following "Sentinel" Distal Radius Fractures [2024]

• Institute for Clinical and Economic Review
  • Osteoporosis

• Journal of Bone and Mineral Research
  • Temporal Trends and Factors Associated with Bisphosphonate Discontinuation and Restart [2020]
  • Osteoporosis Medication Use After Hip Fracture in U.S. Patients Between 2002 and 2011 [2014]

• Journal of Clinical Endocrinology & Metabolism
  • Trends in Osteoporosis Drug Therapy Receipt Among Commercial and Medicare Advantage Enrollees in the United States, 2011-2022 [2025]

• Journal of General Internal Medicine
  • Secular Trends in the Pharmacologic Treatment of Osteoporosis and Malignancy-Related Bone Disease from 2009 to 2020 [2022]

• Journal of Rheumatology
  • Patient Perceptions of Osteoporosis Treatment Thresholds [2014]

• Medical Care
  • Duration of Bisphosphonate Drug Holidays and Associated Fracture Risk [2020]

• Office of Dietary Supplements
  • Calcium - Health Professional Fact Sheet

• Osteoporosis International
  • Cost-effectiveness of Five Versus Ten Years of Alendronate Treatment Prior to Drug Holiday for Women with Osteoporosis [2020]

• PLoS ONE
  • Inadequate calcium and vitamin D intake and osteoporosis risk in older Americans living in poverty with food insecurities [2020]

• Seminars in Arthritis and Rheumatism
  • Cost-effectiveness of sequential treatment with abaloparatide followed by alendronate vs. alendronate monotherapy in women at increased risk of fracture: A US payer perspective [2020]

• Society for Adolescent Health and Medicine
  • Recommended Vitamin D Intake and Management of Low Vitamin D Status in Adolescents: A Position Statement of the Society for Adolescent Health and Medicine [2013]

• StatPearls
  • Zoledronate
  • Denosumab
  • Bisphosphonate
  • Alendronate
  • Abaloparatide

• U.S. Preventive Services Task Force
  • Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Falls and Fractures in Community-Dwelling Adults: Preventive Medication [2024]
  • Vitamin D Deficiency in Adults: Screening [2021]

• Women's Health
  • Efficacy and safety of estrogen therapy for prevention of osteoporosis in postmenopausal women [2026]

{Related topics}

• Topic
  • Osteoporosis: vitamin D
  • Osteoporosis